IOL Chemicals

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE485C01029
  • NSEID: IOLCP
  • BSEID: 524164
INR
85.40
-1.42 (-1.64%)
BSENSE

Dec 05

BSE+NSE Vol: 1.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
2,079.21
2,132.79
2,217.11
2,184.02
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
2,079.21
2,132.79
2,217.11
2,184.02
Raw Material Cost
1,358.34
1,435.05
1,536.07
1,578.91
Purchase of Finished goods
0.00
0.15
29.22
43.90
(Increase) / Decrease In Stocks
33.51
-38.25
-18.20
-52.30
Employee Cost
216.57
201.02
168.21
141.30
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
268.49
304.23
276.14
213.92
Total Expenditure (Excl Depreciation)
1,876.91
1,902.20
1,991.44
1,925.73
Operating Profit (PBDIT) excl Other Income
202.30
230.59
225.67
258.29
Other Income
22.41
30.07
25.61
32.04
Operating Profit (PBDIT)
224.71
260.66
251.28
290.33
Interest
14.76
16.10
16.47
8.29
Exceptional Items
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
209.95
244.56
234.81
268.11
Depreciation
71.99
62.91
46.16
43.26
Profit Before Tax
137.96
181.65
188.65
224.85
Tax
36.89
47.22
49.51
57.18
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
101.07
134.43
139.14
167.67
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
101.07
134.43
139.14
167.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
101.07
134.43
139.14
167.67
Equity Capital
58.71
58.71
58.71
58.71
Face Value
2.0
10.0
10.0
10.0
Reserves
1,628.95
1,552.80
1,449.01
1,333.57
Earnings per share (EPS)
3.44
4.58
23.7
28.56
Diluted Earnings per share
3.44
4.58
23.7
28.56
Operating Profit Margin (Excl OI)
9.73%
10.81%
10.18%
11.83%
Gross Profit Margin
10.1%
11.47%
10.59%
12.28%
PAT Margin
4.86%
6.3%
6.28%
7.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -2.51% vs -3.80% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -24.82% vs -3.39% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -12.27% vs 2.18% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -8.32% vs -2.25% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of IOL Chemicals With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,079.21
782.75
1,296.46
165.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,079.21
782.75
1,296.46
165.63%
Raw Material Cost
1,358.34
501.87
856.47
170.66%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
33.51
-64.81
98.32
151.70%
Employee Cost
216.57
80.08
136.49
170.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
86.35
-86.35
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
268.49
40.26
228.23
566.89%
Total Expenditure (Excl Depreciation)
1,876.91
643.75
1,233.16
191.56%
Operating Profit (PBDIT) excl Other Income
202.30
139.00
63.30
45.54%
Other Income
22.41
6.22
16.19
260.29%
Operating Profit (PBDIT)
224.71
145.22
79.49
54.74%
Interest
14.76
18.54
-3.78
-20.39%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
209.95
126.68
83.27
65.73%
Depreciation
71.99
34.34
37.65
109.64%
Profit Before Tax
137.96
92.34
45.62
49.40%
Tax
36.89
24.94
11.95
47.91%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
101.07
67.40
33.67
49.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
101.07
67.40
33.67
49.96%
Share in Profit of Associates
0.00
1.74
-1.74
-100.00%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
101.07
69.14
31.93
46.18%
Equity Capital
58.71
8.87
49.84
561.89%
Face Value
2.00
1.00
0.00
Reserves
1,628.95
630.78
998.17
158.24%
Earnings per share (EPS)
3.44
7.79
-4.35
-55.84%
Diluted Earnings per share
3.44
8.16
-4.72
-57.84%
Operating Profit Margin (Excl OI)
9.73%
17.76%
0.00
-8.03%
Gross Profit Margin
10.10%
16.18%
0.00
-6.08%
PAT Margin
4.86%
8.61%
0.00
-3.75%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,079.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.51% vs -3.80% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 101.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -24.82% vs -3.39% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 202.30 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -12.27% vs 2.18% in Mar 2024

Annual - Interest
Interest 14.76 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.32% vs -2.25% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.73%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024